Search PDMR transactions

Notifier
Name of person with notification obligation
Karl Martin Erik Åmark
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Karl Martin Erik Åmark
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xbrane Biopharma AB
Issuer’s LEI code
5493008DKD05APTKQO39
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xbrane biopharma Ab SE0007789409 Acquisition 810 Quantity 76.40 SEK 04/01/2021 NASDAQ STOCKHOLM AB
Share Xbrane biopharma ab SE0007789409 Disposal 810 Quantity 76.20 SEK 04/01/2021 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma ab SE0007789409 Acquisition 805 Quantity 77.00 SEK 05/01/2021 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Acquisition 1,150 Quantity 81.60 SEK 08/01/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xbrane biopharma Ab SE0007789409 Acquisition 04/01/2021 NASDAQ STOCKHOLM AB 810 (Quantity) 76.40 SEK
Xbrane biopharma ab SE0007789409 Disposal 04/01/2021 NASDAQ STOCKHOLM AB 810 (Quantity) 76.20 SEK
Xbrane Biopharma ab SE0007789409 Acquisition 05/01/2021 NASDAQ STOCKHOLM AB 805 (Quantity) 77.00 SEK
Xbrane Biopharma AB SE0007789409 Acquisition 08/01/2021 NASDAQ STOCKHOLM AB 1,150 (Quantity) 81.60 SEK
<< Back